Does stage-based smoking cessation advice in pregnancy result in long-term quitters? 18-month postpartum follow-up of a randomized controlled trial. by Lawrence, T, Aveyard, P, Cheng, K, Griffin, C, Johnson, C, Croghan, E

“… AIMS: To evaluate the effect on quitting smoking at 18 months postpartum of smoking cessation interventions based on the Transtheoretical Model (TTM) delivered in pregnancy compared to current standard care. …”

Association between the month of starting a weight management program and weight change in people at high risk of type 2 diabetes: a prospective cohort study by Koutoukidis, D, Barron, E, Stevens, R, Aveyard, P, Valabhji, J, Jebb, S

“…Repeated measures models assessed the mean difference between baseline and follow-up weight adjusting for monthly variation in weight among those with ≥1 weight measurement. …”

Factors associated with smoking cessation in early and late pregnancy in the smoking, nicotine, and pregnancy trial: a trial of nicotine replacement therapy. by Vaz, L, Leonardi-Bee, J, Aveyard, P, Cooper, S, Grainge, M, Coleman, T

“…METHODS: Data were collected at baseline, 1 month, and delivery from 1,050 pregnant women. Two multivariable logistic models for validated cessation at 1 month and delivery were created with a systematic strategy for selection of included factors. …”

A controlled trial of an expert system and self-help manual intervention based on the stages of change versus standard self-help materials in smoking cessation. by Aveyard, P, Griffin, C, Lawrence, T, Cheng, K

“…MEASUREMENTS: Biochemically confirmed point prevalence of being quit and 6-month sustained abstinence, 12 months after study commencement. …”

Early weight gain after stopping smoking: a predictor of overall large weight gain? A single-site retrospective cohort study by Pankova, A, Kralikova, E, Zvolska, K, Stepankova, L, Blaha, M, Ovesna, P, Aveyard, P

“…<strong>Results</strong> The mean weight gain in the first month (n=763) was 0.79% (±2.03%), in the second month (n=646) was 1.49% (±2.58%), for the third month (n=566) 2.33% (±3.44%) and 4.1% (±5.31%) after 1-year follow-up (n=1050). …”

Nicotine preloading for smoking cessation: the Preloading RCT by Aveyard, P, Lindson, N, Tearne, S, Adams, R, Ahmed, K, Alekna, R, Banting, M, Healy, M, Khan, S, Rai, G, Wood, C, Anderson, E, Ataya-Williams, A, Attwood, A, Easey, K, Fluharty, M, Freuler, T, Hurse, M, Khouja, J, Lacey, L, Munafò, M, Lycett, D, McEwen, A, Coleman, T, Dickinson, A, Lewis, S, Orton, S, Perdue, J, Randall, C, Anderson, R, Bisal, N, Hajek, P, Homsey, C, McRobbie, H, Myers-Smith, K, Phillips, A, Przulj, D, Li, J, Coyle, D, Coyle, K, Pokhrel, S

“…The within-trial analysis assessed health-service costs during the 13 months of trial enrolment relative to the previous 6 months comparing trial arms. …”

Provision of smoking cessation support in UK primary care: impact of the 2012 QOF revision. by Szatkowski, L, Aveyard, P

“…From 2012, GPs are now paid to offer all smokers referral for behavioural support and medication to assist cessation at least once every 2 years.To quantify the impact of this new recommendation and payment on indicators of smoking cessation activity.Interrupted time series analysis of data from general practices in England contributing data to The Health Improvement Network (THIN).Data were extracted on monthly rates of recorded delivery of smoking cessation advice, referral to NHS Stop Smoking Services, and prescription of smoking cessation medications, among an average of 3.3 million patients aged &gt;16 years registered each month in THIN. …”

Placebo-controlled trial of cytisine for smoking cessation. by West, R, Zatonski, W, Cedzynska, M, Lewandowska, D, Pazik, J, Aveyard, P, Stapleton, J

“…The 7-day point prevalence for abstinence at the 12-month follow-up was 13.2% in the cytisine group versus 7.3% in the placebo group (P=0.01). …”

Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT by Taylor, AH, Thompson, TP, Streeter, A, Chynoweth, J, Snowsill, T, Ingram, W, Ussher, M, Aveyard, P, Murray, RL, Harris, T, Green, C, Horrell, J, Callaghan, L, Greaves, CJ, Price, L, Cartwright, L, Wilks, J, Campbell, S, Preece, D, Creanor, S

“…Furthermore, self-reported (3 and 9 months) and accelerometer-recorded (3 months) physical activity data were gathered. …”

Association between use of nicotine replacement therapy for harm reduction and smoking cessation: a prospective study of English smokers. by Beard, E, McNeill, A, Aveyard, P, Fidler, J, Michie, S, West, R

“…</p><p>METHOD: Data were collected from 15 539 smokers involved in the Smoking Toolkit Study, a series of monthly household surveys of adults aged 16+; of whom 23% (n=3149) completed a 6-month follow-up questionnaire. …”

Nicotine patch preloading for smoking cessation (the preloading trial): study protocol for a randomized controlled trial. by Lindson-Hawley, N, Coleman, T, Docherty, G, Hajek, P, Lewis, S, Lycett, D, McEwen, A, McRobbie, H, Munafò, MR, Parrott, S, Aveyard, P

“…Follow-ups will take place at one week, four weeks, six months and 12 months after quit day. The primary outcome will be prolonged, biochemically verified six-month abstinence. …”

The association between treatment adherence to nicotine patches and smoking cessation in pregnancy: A secondary analysis of a randomized controlled trial by Vaz, L, Aveyard, P, Cooper, S, Leonardi-Bee, J, Coleman, T

“…Adherence during both treatment months was associated with being randomized to NRT (β 0.51, 95% CI 0.29 to 0.72) and inversely associated with higher nicotine dependence. …”

The effect of referral to an open-group behavioural weight management programme on the relative risk of normoglycaemia, non-diabetic hyperglycaemia and type 2 diabetes: secondary a... by Ahern, AL, Griffin, SJ, Wheeler, GM, Sharp, SJ, Aveyard, P, Boyland, EJ, Halford, JCG, Jebb, SA

“…We used mixed effects models and linear fixed effects models to examine the effect of intervention group on body weight and HbA1c at 12 months in people with NDH.</br> <br><strong>Results: </strong>There was a 61% relative reduction in the risk of NDH at the 12‐month follow‐up (12 weeks vs. …”

Effectiveness and cost-effectiveness of behavioural support for prolonged abstinence for smokers wishing to reduce but not quit: Randomised controlled trial of physical activity as... by Taylor, AH, Thompson, TP, Streeter, A, Chynoweth, J, Snowsill, T, Ingram, W, Ussher, M, Aveyard, P, Murray, RL, Harris, T, Callaghan, L, Green, C, Greaves, CJ, Price, L, Creanor, S

“…</p> <p><strong>Measurements:</strong> Ideally, cessation follows smoking reduction so the primary pre-defined outcome was biochemically verified 6-month prolonged abstinence (from 3–9 months, with a secondary endpoint also considering abstinence between 9 and 15 months). …”

Synthesis of evidence on heterogeneous interventions with multiple outcomes recorded over multiple follow-up times reported inconsistently: a smoking cessation case-study by Madan, J, Chen, Y, Aveyard, P, Wang, D, Yahaya, I, Munafo, M, Bauld, L, Welton, N

“…Furthermore, there were differences between studies in the number and timing of follow-up times reported, whereas 12-month continuous abstinence is required in the cost-effectiveness analysis. …”

Regular self-weighing to promote weight maintenance after intentional weight loss: a quasi-randomized controlled trial. by Madigan, C, Aveyard, P, Jolly, K, Denley, J, Lewis, A, Daley, A

“…The main outcome was change in weight between 3 and 12 months.</p><p>RESULTS: Using intention to treat analysis both groups regained weight; however, the intervention group on average regained 1.23 kg, whereas the control group regained 1.83 kg. …”

Synthesis of evidence on heterogeneous interventions with multiple outcomes recorded over multiple follow-up times reported inconsistently: A smoking cessation case-study by Madan, J, Chen, Y, Aveyard, P, Wang, D, Yahaya, I, Munafo, M, Bauld, L, Welton, N

“…Furthermore, there were differences between studies in the number and timing of follow-up times reported, whereas 12-month continuous abstinence is required in the cost-effectiveness analysis. …”

Managing smoking cessation‑related weight gain. by Aveyard, P, Lycett, D, Farley, A

“…Instead, it may be prudent to monitor weight gain after cessation and intervene with people gaining more than 1 kg/month. There is some evidence that weight gain after cessation can be prevented by dietary intervention that includes setting an energy intake goal and regular monitoring of weight and adjustment of energy intake. …”

Is advice to stop smoking from a midwife stressful for pregnant women who smoke? Data from a randomized controlled trial. by Aveyard, P, Lawrence, T, Croghan, E, Evans, O, Cheng, K

“…Stress was assessed by the change in score on the Perceived Stress Scale (PSS) from baseline to 30 weeks gestation, the month before delivery, and 10 days postpartum. RESULTS: There were small and not significant differences in the changes in PSS between the arms at all outcome times. …”

Randomised controlled trial of tailored support to increase physical activity and reduce smoking in smokers not immediately ready to quit: protocol for the Trial of physical Activi... by Taylor, A, Thompson, TP, Ussher, M, Aveyard, P, Murray, RL, Harris, T, Creanor, S, Green, C, Streeter, AJ, Chynoweth, J, Ingram, W, Greaves, CJ, Hancocks, H, Snowsill, T, Callaghan, L, Price, L, Horrell, J, King, J, Gude, A, George, M, Wahlich, C, Hamilton, L, Cheema, K, Campbell, S, Preece, D

“…The primary outcome measure is 6-month carbon monoxide-confirmed floating prolonged abstinence following participant self-reported quitting on a mailed questionnaire at 3 and 9&#x2009;months post-baseline. …”